Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis.

Burghaus S, Hildebrandt T, Fahlbusch C, Heusinger K, Antoniadis S, Lermann J, Hackl J, Häberle L, Renner SP, Fasching PA, Beckmann MW, Blum S.

Geburtshilfe Frauenheilkd. 2019 May;79(5):487-497. doi: 10.1055/a-0813-4411. Epub 2019 Feb 28.

2.

Situation of Adolescent Contraceptive Use in Germany.

Oppelt PG, Fahlbusch C, Heusinger K, Lotz L, Dittrich R, Baier F.

Geburtshilfe Frauenheilkd. 2018 Oct;78(10):999-1007. doi: 10.1055/a-0684-9838. Epub 2018 Oct 19.

3.

Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound.

Häberle L, Hack CC, Heusinger K, Wagner F, Jud SM, Uder M, Beckmann MW, Schulz-Wendtland R, Wittenberg T, Fasching PA.

Eur J Med Res. 2017 Aug 30;22(1):30. doi: 10.1186/s40001-017-0270-0.

4.

Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis.

Hack CC, Emons J, Jud SM, Heusinger K, Adler W, Gass P, Haeberle L, Heindl F, Hein A, Schulz-Wendtland R, Uder M, Hartmann A, Beckmann MW, Fasching PA, Pöhls UG.

Breast Cancer Res Treat. 2017 Dec;166(3):701-708. doi: 10.1007/s10549-017-4446-7. Epub 2017 Aug 21.

PMID:
28828694
5.

Correlation of mammographic density and serum calcium levels in patients with primary breast cancer.

Hack CC, Stoll MJ, Jud SM, Heusinger K, Adler W, Haeberle L, Ganslandt T, Heindl F, Schulz-Wendtland R, Cavallaro A, Uder M, Beckmann MW, Fasching PA, Bayer CM.

Cancer Med. 2017 Jun;6(6):1473-1481. doi: 10.1002/cam4.1066. Epub 2017 May 2.

6.

What do patients want to know about contraception and which method would they prefer?

Oppelt PG, Baier F, Fahlbusch C, Heusinger K, Hildebrandt T, Breuel C, Dittrich R.

Arch Gynecol Obstet. 2017 Jun;295(6):1483-1491. doi: 10.1007/s00404-017-4373-1. Epub 2017 Apr 22.

PMID:
28434106
7.

Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy.

Schulz-Wendtland R, Dankerl P, Bani MR, Fasching PA, Heusinger K, Lux MP, Jud SM, Rauh C, Bayer CM, Schrauder MG, Beckmann MW, Uder M, Brehm B, Loehberg CR.

Geburtshilfe Frauenheilkd. 2017 Feb;77(2):169-175. doi: 10.1055/s-0042-124191.

8.

Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience.

Beckmann MW, Dittrich R, Lotz L, Oppelt PG, Findeklee S, Hildebrandt T, Heusinger K, Cupisti S, Müller A.

Arch Gynecol Obstet. 2017 Apr;295(4):1033-1039. doi: 10.1007/s00404-017-4311-2. Epub 2017 Feb 15.

PMID:
28197717
10.

The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and Patients.

Burghaus S, Fehm T, Fasching PA, Blum S, Renner SK, Baier F, Brodkorb T, Fahlbusch C, Findeklee S, Häberle L, Heusinger K, Hildebrandt T, Lermann J, Strahl O, Tchartchian G, Bojahr B, Porn A, Fleisch M, Reicke S, Füger T, Hartung CP, Hackl J, Beckmann MW, Renner SP.

Geburtshilfe Frauenheilkd. 2016 Aug;76(8):875-881.

11.

Mammographic density is the main correlate of tumors detected on ultrasound but not on mammography.

Häberle L, Fasching PA, Brehm B, Heusinger K, Jud SM, Loehberg CR, Hack CC, Preuss C, Lux MP, Hartmann A, Vachon CM, Meier-Meitinger M, Uder M, Beckmann MW, Schulz-Wendtland R.

Int J Cancer. 2016 Nov 1;139(9):1967-74. doi: 10.1002/ijc.30261. Epub 2016 Jul 19.

12.

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

Findeklee S, Lotz L, Heusinger K, Hoffmann I, Dittrich R, Beckmann MW.

Geburtshilfe Frauenheilkd. 2015 Dec;75(12):1243-1249. Review.

13.

Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study.

Burghaus S, Häberle L, Schrauder MG, Heusinger K, Thiel FC, Hein A, Wachter D, Strehl J, Hartmann A, Ekici AB, Renner SP, Beckmann MW, Fasching PA.

BMC Cancer. 2015 Oct 21;15:751. doi: 10.1186/s12885-015-1821-9.

14.

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

Darabi H, McCue K, Beesley J, Michailidou K, Nord S, Kar S, Humphreys K, Thompson D, Ghoussaini M, Bolla MK, Dennis J, Wang Q, Canisius S, Scott CG, Apicella C, Hopper JL, Southey MC, Stone J, Broeks A, Schmidt MK, Scott RJ, Lophatananon A, Muir K, Beckmann MW, Ekici AB, Fasching PA, Heusinger K, Dos-Santos-Silva I, Peto J, Tomlinson I, Sawyer EJ, Burwinkel B, Marme F, Guénel P, Truong T, Bojesen SE, Flyger H, Benitez J, González-Neira A, Anton-Culver H, Neuhausen SL, Arndt V, Brenner H, Engel C, Meindl A, Schmutzler RK; German Consortium of Hereditary Breast and Ovarian Cancer, Arnold N, Brauch H, Hamann U, Chang-Claude J, Khan S, Nevanlinna H, Ito H, Matsuo K, Bogdanova NV, Dörk T, Lindblom A, Margolin S; kConFab/AOCS Investigators, Kosma VM, Mannermaa A, Tseng CC, Wu AH, Floris G, Lambrechts D, Rudolph A, Peterlongo P, Radice P, Couch FJ, Vachon C, Giles GG, McLean C, Milne RL, Dugué PA, Haiman CA, Maskarinec G, Woolcott C, Henderson BE, Goldberg MS, Simard J, Teo SH, Mariapun S, Helland Å, Haakensen V, Zheng W, Beeghly-Fadiel A, Tamimi R, Jukkola-Vuorinen A, Winqvist R, Andrulis IL, Knight JA, Devilee P, Tollenaar RA, Figueroa J, García-Closas M, Czene K, Hooning MJ, Tilanus-Linthorst M, Li J, Gao YT, Shu XO, Cox A, Cross SS, Luben R, Khaw KT, Choi JY, Kang D, Hartman M, Lim WY, Kabisch M, Torres D, Jakubowska A, Lubinski J, McKay J, Sangrajrang S, Toland AE, Yannoukakos D, Shen CY, Yu JC, Ziogas A, Schoemaker MJ, Swerdlow A, Borresen-Dale AL, Kristensen V, French JD, Edwards SL, Dunning AM, Easton DF, Hall P, Chenevix-Trench G.

Am J Hum Genet. 2015 Jul 2;97(1):22-34. doi: 10.1016/j.ajhg.2015.05.002. Epub 2015 Jun 11.

15.

Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures.

Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, Kraft P, Hazra A, Li J, Eriksson L, Czene K, Hall P, Jensen M, Cunningham J, Olson JE, Purrington K, Couch FJ, Brown J, Leyland J, Warren RM, Luben RN, Khaw KT, Smith P, Wareham NJ, Jud SM, Heusinger K, Beckmann MW, Douglas JA, Shah KP, Chan HP, Helvie MA, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman C, Giles GG, Baglietto L, Krishnan K, Southey MC, Apicella C, Andrulis IL, Knight JA, Ursin G, Alnaes GI, Kristensen VN, Borresen-Dale AL, Gram IT, Bolla MK, Wang Q, Michailidou K, Dennis J, Simard J, Pharoah P, Dunning AM, Easton DF, Fasching PA, Pankratz VS, Hopper JL, Vachon CM.

Cancer Res. 2015 Jun 15;75(12):2457-67. doi: 10.1158/0008-5472.CAN-14-2012. Epub 2015 Apr 10.

16.

The contributions of breast density and common genetic variation to breast cancer risk.

Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ.

J Natl Cancer Inst. 2015 Mar 4;107(5). pii: dju397. doi: 10.1093/jnci/dju397. Print 2015 May.

17.

Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker Clips.

Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Wachter DL, Uder M, Meier-Meitinger M, Brehm B.

Geburtshilfe Frauenheilkd. 2015 Jan;75(1):72-76.

18.

Association of molecular subtypes with breast cancer risk factors: a case-only analysis.

Rauh C, Gass P, Heusinger K, Haeberle L, Jud SM, Hein A, Loehberg CR, Lux MP, Wachter DL, Heimrich J, Strehl JD, Haller F, Hartmann A, Schulz-Wendtland R, Fiessler C, Beckmann MW, Fasching PA, Poehls U.

Eur J Cancer Prev. 2015 Nov;24(6):484-90. doi: 10.1097/CEJ.0000000000000111.

PMID:
25494290
19.

Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy?

Schulz-Wendtland R, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Brehm B, Hammon M, Saake M, Dankerl P, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M.

Geburtshilfe Frauenheilkd. 2013 May;73(5):422-427.

20.

Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Fasching PA, Ekici AB, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Schneider M, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1228-1235.

21.

Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer.

Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M, Brehm B.

Geburtshilfe Frauenheilkd. 2013 Nov;73(11):1135-1138.

22.

Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients.

Hein A, Bayer CM, Schrauder MG, Häberle L, Heusinger K, Strick R, Ruebner M, Lux MP, Renner SP, Schulz-Wendtland R, Ekici AB, Hartmann A, Beckmann MW, Fasching PA.

Biomed Res Int. 2014;2014:842452. doi: 10.1155/2014/842452. Epub 2014 Mar 5.

23.

Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors.

Lux MP, Bayer CM, Loehberg CR, Fasching PA, Schrauder MG, Bani MR, Häberle L, Engel A, Heusinger K, Tänzer T, Radosavac D, Scharl A, Bauerfeind I, Gesslein J, Schulte H, Overbeck-Schulte B, Beckmann MW, Hein A.

Breast Cancer Res Treat. 2013 Jun;139(2):429-40. doi: 10.1007/s10549-013-2557-3. Epub 2013 May 14.

PMID:
23670130
24.

Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.

Loehberg CR, Almstedt K, Jud SM, Haeberle L, Fasching PA, Hack CC, Lux MP, Thiel FC, Schrauder MG, Brunner M, Bayer CM, Hein A, Heusinger K, Heimrich J, Bani MR, Renner SP, Hartmann A, Beckmann MW, Wachter DL.

Breast Cancer Res Treat. 2013 Apr;138(3):899-908. doi: 10.1007/s10549-013-2460-y. Epub 2013 Mar 12.

PMID:
23479421
25.

Mammographic Density and Prediction of Nodal Status in Breast Cancer Patients.

Hack CC, Häberle L, Geisler K, Schulz-Wendtland R, Hartmann A, Fasching PA, Uder M, Wachter DL, Jud SM, Loehberg CR, Lux MP, Rauh C, Beckmann MW, Heusinger K.

Geburtshilfe Frauenheilkd. 2013 Feb;73(2):136-141.

26.

Factors influencing breast changes after pregnancy.

Rauh C, Faschingbauer F, Haeberle L, Jud SM, Heusinger K, Fasching PA, Goecke TW, Rajakaruna N, Voigt F, Bani MR, Lux MP, Renner SP, Loehberg CR, Hartmann A, Schulz-Wendtland R, Beckmann MW, Bayer CM.

Eur J Cancer Prev. 2013 May;22(3):259-61. doi: 10.1097/CEJ.0b013e328359cb81.

PMID:
23022745
27.

Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer.

Heusinger K, Jud SM, Häberle L, Hack CC, Fasching PA, Meier-Meitinger M, Lux MP, Hagenbeck C, Loehberg CR, Wittenberg T, Rauh C, Wagner F, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Wachter DL.

Breast Cancer Res Treat. 2012 Oct;135(3):885-92. doi: 10.1007/s10549-012-2221-3. Epub 2012 Aug 31.

PMID:
22936391
28.

Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer.

Rauh C, Hack CC, Häberle L, Hein A, Engel A, Schrauder MG, Fasching PA, Jud SM, Ekici AB, Loehberg CR, Meier-Meitinger M, Ozan S, Schulz-Wendtland R, Uder M, Hartmann A, Wachter DL, Beckmann MW, Heusinger K.

Geburtshilfe Frauenheilkd. 2012 Aug;72(8):727-733.

29.

Characterizing mammographic images by using generic texture features.

Häberle L, Wagner F, Fasching PA, Jud SM, Heusinger K, Loehberg CR, Hein A, Bayer CM, Hack CC, Lux MP, Binder K, Elter M, Münzenmayer C, Schulz-Wendtland R, Meier-Meitinger M, Adamietz BR, Uder M, Beckmann MW, Wittenberg T.

Breast Cancer Res. 2012 Apr 10;14(2):R59.

30.

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk.

Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernández-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate M, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, Thompson DJ, Luben RN, Warren RM, Wareham NJ, Loos RJ, Khaw KT, Ursin G, Lee E, Gayther SA, Ramus SJ, Eeles RA, Leach MO, Kwan-Lim G, Couch FJ, Giles GG, Baglietto L, Krishnan K, Southey MC, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman CA, Walker K, Johnson N, McCormack VA, Biong M, Alnaes GI, Gram IT, Kristensen VN, Børresen-Dale AL, Lindström S, Hankinson SE, Hunter DJ, Andrulis IL, Knight JA, Boyd NF, Figuero JD, Lissowska J, Wesolowska E, Peplonska B, Bukowska A, Reszka E, Liu J, Eriksson L, Czene K, Audley T, Wu AH, Pankratz VS, Hopper JL, dos-Santos-Silva I.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1156-66. doi: 10.1158/1055-9965.EPI-12-0066. Epub 2012 Mar 27.

31.

Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study.

Heusinger K, Jud SM, Häberle L, Hack CC, Adamietz BR, Meier-Meitinger M, Lux MP, Wittenberg T, Wagner F, Loehberg CR, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Fasching PA.

Int J Cancer. 2012 Dec 1;131(11):2643-9. doi: 10.1002/ijc.27515. Epub 2012 Mar 28.

32.

Breast Cancer Risk - Genes, Environment and Clinics.

Fasching PA, Ekici AB, Adamietz BR, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2011 Dec;71(12):1056-1066.

33.

Correlates of mammographic density in B-mode ultrasound and real time elastography.

Jud SM, Häberle L, Fasching PA, Heusinger K, Hack C, Faschingbauer F, Uder M, Wittenberg T, Wagner F, Meier-Meitinger M, Schulz-Wendtland R, Beckmann MW, Adamietz BR.

Eur J Cancer Prev. 2012 Jul;21(4):343-9. doi: 10.1097/CEJ.0b013e32834e3214.

PMID:
22123663
34.

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.

Fasching PA, Heusinger K, Haeberle L, Niklos M, Hein A, Bayer CM, Rauh C, Schulz-Wendtland R, Bani MR, Schrauder M, Kahmann L, Lux MP, Strehl JD, Hartmann A, Dimmler A, Beckmann MW, Wachter DL.

BMC Cancer. 2011 Nov 14;11:486. doi: 10.1186/1471-2407-11-486.

35.

Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients.

Meier-Meitinger M, Rauh C, Adamietz B, Fasching PA, Schwab SA, Haeberle L, Hein A, Bayer CM, Bani MR, Lux MP, Hartmann A, Wachter DL, Uder M, Schulz-Wendtland R, Beckmann MW, Heusinger K.

Eur J Surg Oncol. 2012 Jan;38(1):44-51. doi: 10.1016/j.ejso.2011.10.008. Epub 2011 Oct 26.

PMID:
22032911
36.

Breast volumetry using a three-dimensional surface assessment technique.

Koch MC, Adamietz B, Jud SM, Fasching PA, Haeberle L, Karbacher S, Veit K, Schulz-Wendtland R, Uder M, Beckmann MW, Bani MR, Heusinger K, Loehberg CR, Cavallaro A.

Aesthetic Plast Surg. 2011 Oct;35(5):847-55. doi: 10.1007/s00266-011-9708-x. Epub 2011 Apr 13.

PMID:
21487916
37.

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.

Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benítez J, Arias Pérez JI, Zamora MP, Malats N, Dos Santos Silva I, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman ME, Lissowska J, Hopper JL, Dite GS, Apicella C, Southey MC, Sigurdson AJ, Linet MS, Schonfeld SJ, Freedman DM, Mannermaa A, Kosma VM, Kataja V, Auvinen P, Andrulis IL, Glendon G, Knight JA, Weerasooriya N, Cox A, Reed MW, Cross SS, Dunning AM, Ahmed S, Shah M, Brauch H, Ko YD, Brüning T; GENICA Network, Lambrechts D, Reumers J, Smeets A, Wang-Gohrke S, Hall P, Czene K, Liu J, Irwanto AK, Chenevix-Trench G, Holland H; kConFab; AOCS, Giles GG, Baglietto L, Severi G, Bojensen SE, Nordestgaard BG, Flyger H, John EM, West DW, Whittemore AS, Vachon C, Olson JE, Fredericksen Z, Kosel M, Hein R, Vrieling A, Flesch-Janys D, Heinz J, Beckmann MW, Heusinger K, Ekici AB, Haeberle L, Humphreys MK, Morrison J, Easton DF, Pharoah PD, García-Closas M, Goode EL, Chang-Claude J.

Breast Cancer Res. 2010;12(6):R110. doi: 10.1186/bcr2797. Epub 2010 Dec 31.

38.

Assessment of breast cancer tumour size using six different methods.

Meier-Meitinger M, Häberle L, Fasching PA, Bani MR, Heusinger K, Wachter D, Beckmann MW, Uder M, Schulz-Wendtland R, Adamietz B.

Eur Radiol. 2011 Jun;21(6):1180-7. doi: 10.1007/s00330-010-2016-z. Epub 2010 Dec 30.

PMID:
21191794
39.

Diabetes and prognosis in a breast cancer cohort.

Schrauder MG, Fasching PA, Häberle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, Wachter DL, Schulz-Wendtland R, Adamietz B, Beckmann MW, Loehberg CR.

J Cancer Res Clin Oncol. 2011 Jun;137(6):975-83. doi: 10.1007/s00432-010-0960-2. Epub 2010 Dec 5.

PMID:
21132511
40.

Mammographic density as a risk factor for breast cancer in a German case-control study.

Heusinger K, Loehberg CR, Haeberle L, Jud SM, Klingsiek P, Hein A, Bayer CM, Rauh C, Uder M, Cavallaro A, May MS, Adamietz B, Schulz-Wendtland R, Wittenberg T, Wagner F, Beckmann MW, Fasching PA.

Eur J Cancer Prev. 2011 Jan;20(1):1-8. doi: 10.1097/CEJ.0b013e328341e2ce.

PMID:
21102341
41.

Assessment of mammographic density before and after first full-term pregnancy.

Loehberg CR, Heusinger K, Jud SM, Haeberle L, Hein A, Rauh C, Bani MR, Lux MP, Schrauder MG, Bayer CM, Helbig C, Grolik R, Adamietz B, Schulz-Wendtland R, Beckmann MW, Fasching PA.

Eur J Cancer Prev. 2010 Nov;19(6):405-12. doi: 10.1097/CEJ.0b013e32833ca1f4.

PMID:
20700056
42.

Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.

Loehberg CR, Jud SM, Haeberle L, Heusinger K, Dilbat G, Hein A, Rauh C, Dall P, Rix N, Heinrich S, Buchholz S, Lex B, Reichler B, Adamietz B, Schulz-Wendtland R, Beckmann MW, Fasching PA.

Breast Cancer Res Treat. 2010 May;121(1):101-10. doi: 10.1007/s10549-010-0845-8. Epub 2010 Mar 21.

PMID:
20306293
43.

Pain perception and detailed visual pain mapping in breast cancer survivors.

Jud SM, Fasching PA, Maihöfner C, Heusinger K, Loehberg CR, Hatko R, Rauh C, Bani H, Lux MP, Beckmann MW, Bani MR.

Breast Cancer Res Treat. 2010 Jan;119(1):105-10. doi: 10.1007/s10549-009-0485-z. Epub 2009 Jul 30.

PMID:
19641989
44.

Factors correlating with reexcision after breast-conserving therapy.

Bani MR, Lux MP, Heusinger K, Wenkel E, Magener A, Schulz-Wendtland R, Beckmann MW, Fasching PA.

Eur J Surg Oncol. 2009 Jan;35(1):32-7. doi: 10.1016/j.ejso.2008.04.008. Epub 2008 Jun 9.

PMID:
18539425
45.

Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.

Schrauder M, Frank S, Strissel PL, Lux MP, Bani MR, Rauh C, Sieber CC, Heusinger K, Hartmann A, Schulz-Wendtland R, Strick R, Beckmann MW, Fasching PA.

J Cancer Res Clin Oncol. 2008 Aug;134(8):873-82. doi: 10.1007/s00432-008-0355-9. Epub 2008 Feb 9.

PMID:
18264724
46.

Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics.

Fasching PA, Heusinger K, Loehberg CR, Wenkel E, Lux MP, Schrauder M, Koscheck T, Bautz W, Schulz-Wendtland R, Beckmann MW, Bani MR.

Eur J Radiol. 2006 Dec;60(3):398-404. Epub 2006 Oct 9.

PMID:
17030108
47.

Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself*.

Heusinger K, Löhberg C, Lux MP, Papadopoulos T, Imhoff K, Schulz-Wendtland R, Beckmann MW, Fasching PA.

Breast Cancer Res Treat. 2005 Nov;94(1):17-23.

PMID:
16142441

Supplemental Content

Loading ...
Support Center